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Objective: To assess the frequency and types of drug-related problems (DRPs) in patients seeking emer-
gency care in a teaching hospital in southern Brazil and to identify the possible causes and drugs involved
in these problems.
Method: A cross-sectional study was performed, using a structured questionnaire for data collection.
Multivariate logistic regression was used to control for possible confounding factors and to establish an
independent association between the presence of DRPs and the amount of medication, patient’s age and
their educational level.
Results: A total of 350 patients were interviewed. The frequency of DRPs was 31.6%. Quantitative inef-
fectiveness was observed in 30.9% of DRPs and the main cause of the DRP was an inadequate dosing
regimen. Sixty-six DRPs (53.7%) were caused by the health system or the health professionals. Factors
independently inﬂuencing the development of DRPs were educational level and the number of drugs
being taken.
Conclusions: Ourdata suggest that one-third of thepatients attending the emergency roomof our hospital
hadadrug-relatedproblem,highlighting the importanceof consideringdrugs as apossible causeof health
problems and the need for their more rational use.
© 2011 SESPAS. Published by Elsevier España, S.L. All rights reserved.
Problemas relacionados con medicamentos en el servicio de urgencias de un
hospital en el sur de Brasil
alabras clave:
roblemas relacionados con medicamentos
ervicio de urgencias
so de medicamentos
eacciones adversas a medicamentos
tención farmacéutica
r e s u m e n
Objetivo: Evaluar la frecuencia y el tipo de problemas relacionados con medicamentos que presentan los
pacientes que acuden al servicio de urgencias en un hospital universitario del sur de Brasil, e identiﬁcar
las posibles causas y los fármacos involucrados.
Método: La investigación siguió el modelo de estudio transversal, con una encuesta estructurada para la
recogida de los datos. Se empleó el análisis de regresión logísticamúltiple para controlar posibles factores
de confusión y establecer una asociación independiente entre la presencia de problemas relacionados con
medicamentos y el número de éstos, la edad y el nivel educativo.
Resultados: Se entrevistaron 350 pacientes y la frecuencia de problemas relacionados con medicamentos
fue del 31,6%. La inefectividad cuantitativa se observó en el 30,9% de los casos. La principal causa de
los problemas fue el régimen de dosiﬁcación inadecuado. El sistema de salud o los profesionales de la
salud se identiﬁcaron como responsables en 66 casos (53,7%). El nivel educativo y el número de fármacos
contribuyeron de forma independiente a la aparición de los problemas.
Conclusión: Los datos sugieren que un tercio de los pacientes que buscan atención en el servicio
de urgencias del hospital donde se ha realizado el estudio lo hicieron por problemas rela-
cionados con medicamentos, lo que refuerza la importancia de considerar a los fármacos como
una posible causa de problemas de salud y la necesidad de promover un uso más racional de
ellos.
© 2011 SESPAS. Publicado por Elsevier España, S.L. Todos los derechos reservados.ntroductionAlthough many efforts have been made to enforce the rational
se of drugs, several studies have reported drug-induced health
roblems.1–3 The most commonly mentioned factors involved
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213-9111/$ – see front matter © 2011 SESPAS. Published by Elsevier España, S.L. All righ
oi:10.1016/j.gaceta.2011.05.016in these problems are the social pressures to which prescribers
are subjected, the structure of the health system and pharma-
ceutical marketing.4 Patients also play an important role in this
phenomenon, since they may agree to treatment and then show
only partial adherence or may simply decide not to adhere to the
treatment.5
The large-scale use of drugs may create situations that do not
followpharmacotherapeutical principles. These situations are clas-
siﬁed as drug-related problems (DRPs).6 The ﬁrst studies on the
ts reserved.
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wFigure 1. Location of the interviews carried out in the patient care ﬂowchart.
ubject date back to the early 1970s and those reporting this type
f research in emergency rooms (ER) appeared in the following
ecade.
A recent study reported that around 90% of DRPs are
reventable.7 The ability to prevent these events is essential
o identify possible causes and structurally-related factors. Few
ublished studies that have focussed on this issue. Therapy opti-
ization aimed at preventing DRPs improves health, reduces
orbidity and increases quality of life.8
Published studies report DRPs as a frequent cause of visits to
mergency services and hospitalization8,9 and data on this topic
re scarce in developing countries. The aim of the present study
as to assess the frequency and types of DRPs in patients seeking
mergency care in a teaching hospital in southern Brazil and to
dentify the possible causes and drugs involved.
ethod
This cross-sectional studywas conducted at the ER of theHospi-
al de Clínicas de Porto Alegre (Brazil) for 1 month, which provides
mergency care to approximately 65,700 patients annually from
orto Alegre (63.9%) and from other areas (36.1%) in southern
razil.10
A structured questionnaire was used to collect data. The devel-
pment of this questionnairehaspreviously beenpublished.11 Data
ollection was performed by a properly trained and validated team
f interviewers in three emergency care shifts (morning, afternoon
nd night) every day of the week for 20 days. The interviews were
arried out as illustrated in the patient care ﬂowchart (Fig. 1) before
he patient was seen by a doctor. Data on the reasons for consul-
ation, the basic illness, hospitalization, symptoms, measurements
f blood pressure and blood glucose level were collected or con-
rmed in the emergency department records after the physician
onsultation. If the patient was hospitalized, the medical records
ere consulted.it. 2011;25(6):501–506
Calculation of the sample size was based on a previous study2
that estimated a DRP prevalence of 24.3% in an ER in Spain.
Based on an annually-served population of 65,700 patients, a
signiﬁcance level of p≤0.05 and variation of 5%, the estimatedmin-
imum number of individuals needed for interview was 281. This
study included patients older than 12 years who were capable of
expressing themselves or who were accompanied by a caregiver.
Caregivers answered all questions and were present at the medical
consultation. When the patient could not remember any informa-
tion during the interview, the questionnaire was completed later
via a telephone contact.
The review board of our institution, which is accredited by the
Ofﬁce of Human Research Protections as an Institutional Review
Board, approved the ethical and methodological aspects of the
project, and all patients signed a written informed consent form
to participate in this study.
DRPs were identiﬁed case by case, based on the classiﬁcation
of the Brazilian Pharmaceutical Care Consensus.12 In line with
the basic principles of pharmacotherapy, DRPs were classiﬁed by
evaluating three distinct criteria of pharmacotherapy: indication,
effectiveness and safety. Suspected adverse drug reactions (ADR)
were classiﬁed according to Naranjo’s algorithm.13 The causality of
the remaining DRPs was inferred by using data from the question-
naire and the emergency department records.
To estimate interobserver variability, 67 random cases (20%)
were analyzed by a second pharmacist. No divergence in classi-
ﬁcation was found.
Patients who were classiﬁed in the polypharmaceutic
category14 were those who had used ﬁve drugs or more con-
comitantly for 10 days before seeking emergency care. The drugs
were classiﬁed according to the Anatomical Therapeutic Chemical
system.15 The analysis was performed using Epi Info® 6.0 and
SPSS 18.0 software. A descriptive analysis using measures of
central tendency and dispersion of the sample was performed. The
magnitude of the associations was estimated by odds ratios (OR)
with a conﬁdence interval of 95% (CI95%). The chi-square test was
used to determine statistical signiﬁcance between proportions.
To control for possible confounding factors and to establish an
independent association between the presence of DRPs and the
number of medications, age and educational level, a multivariate
logistic regression analysis was performed. The model included
variables with a p value of <0.20.
Results
Sample characterization
Three hundred and ﬁfty patients were interviewed, of whom 15
were excluded due to lack of data. Consequently, the ﬁnal sample
was composed of 335 patients (Fig. 1), who were predominantly
female (65.7%) and white (76.7%). The mean age was 44.9 years
(SD=19.2). Most (61.4%) had elementary education and were from
the metropolitan area of Porto Alegre (94.9%) (Table 1).
Drug-related problems
Of the 335 patients, 106 (31.6%; CI95%: 26.7–36.9) sought emer-
gency care due to DRPs. A total of 123 DRPs were observed,
representing1.2DRPsperpatient, since17 (16%)patientspresented
two DRPs. Univariate analysis showed that age, educational level
and the amount of medication were signiﬁcantly associated with
the development of DRPs (Table 1).Multiple logistic regressionwas
performed to evaluate the impact of age, educational level, and the
number of drugs on the presence of DRPs. Age showed no correla-
tion with the development of DRPs (OR=1.14; CI95%: 0.65–2.11).
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Table 1
Patient characteristics of patients, according to the presence of drug-related problems.
Characteristics No DRP (n=229)n (%) With DRP (n=106)n (%) Total (n =335)n (%) Signiﬁcance
p
Age, mean (standard deviation) 42.9 (18.7) 49.3 (19.7) 44.9 (19.2) 0.030
12 to 64 years old 189 (82.5) 76 (71.7) 265 (79)
65 years or older 40 (17.5) 30 (28.3) 70 (21)
Gender
Female 154 (67.2) 66 (62.3) 220 (65.7) 0.459
Male 75 (32.8) 40 (37.7) 115 (34.3)
Polypharmacy user
Up to four drugs 192 (84) 70 (66) 262 (78) 0.001
Five drugs or more 37 (16) 36 (34) 73 (22)
Educational level
No schooling 8 (3.5) 11 (10.4) 19 (5.7)
Elementary education 131 (57.2) 75 (70.8) 206 (61.4) 0.001
High school education 75 (32.8) 12 (11.3) 87 (26)
Higher education degree 15 (6.5) 8 (7.5) 23 (6.9)
Origin
Metropolitan region 218 (95.2) 100 (94.3) 318 (94.9)
Countryside 8 (3.5) 6 (5.7) 14 (4.2) 0.331
Other states 3 (1.3) 3 (0.9)
Skin color
Caucasian 174 (76.0) 83 (78.3) 257 (76.7)
Black 21 (9.2) 8 (7.5) 29 (8.7) 0.503
Mixed 34 (14.8) 14 (13.2) 48 (14.3)
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RP: drug-related problems.
high school educational level was a protective factor against the
evelopment of DRPs (OR=0.32; CI95%: 0.16–0.64). The use of ﬁve
rmoredrugs contributed independently to theoccurrenceofDRPs
OR=2.21; CI95%: 1.3–3.9) (Table 2).
The most frequent DRPs were ineffectiveness and unsafe use,
espectively (Table 3). Ineffectiveness was related mainly to inad-
quate dosage regimens (22 cases; 17.9%) and refractoriness (15
ases; 12.2%). Adverse drug reactions were the principal cause of
afety problems (35 cases; 28.5%).
actors involved in drug-related problems
In 21 DRPs (17.1%) the patient was identiﬁed as the main
ausative factor. Themost common reasonswere lack of adherence
o treatment and self-medication. The drug itself was linked to 36
RPs (29.3%). The remaining 66 DRPs (53.7%) could be attributed
o the health system itself or to healthcare professionals.rugs most commonly involved in drug-related problems
Of the 71 drugs related to DRPs, the most frequently involved
ere those acting on the cardiovascular system (24.3%) and on the
able 2
ariables independently associated with the presence of drug related problems.
Characteristics Odds ratio Conﬁdence
interval 95%
Signiﬁcance
p
Age
<65 years 1 - -
65 years or older 1.14 0.65–2.11 0.688
Polypharmacy user
Up to four drugs 1 - -
Five drugs or more 2.21 1.3–3.9 0.005
Educational level
No schooling 1.93 0.69–5.40 0.210
Elementary education 1 - -
High school education 0.32 0.16–0.64 0.001
Higher education degree 1.02 0.41–2.57 0.969.9) 1 (0.3)
nervous system (18.6%). These drug groups contain agents such as
captopril (reported in 11 DRPs) and lithium carbonate (reported
in 6 DRPs). Over-the-counter drugs formed a group of nine drugs
(12.7%), which were reported in 16 DRPs (13%).
Discussion
In this study, the frequency of DRPs is higher than that reported
by other authors, who found frequencies ranging from 24.3% to
29.0%.2,4,16 The number of DRPs per patient was similar to that
found by Martínez-Romero et al17 (1.1 DRPs/patient). Our results
agree with those reported in published studies that demonstrate
that the number of drugs in use is related to the development of
DRPs.2,4,18,19 Additionally, this study shows that patients with a
high school education have a lower odds of developing DRPs than
those with less schooling.
Indication-related drug-related problems
The reasons for non-adherence to the treatment prescribed
were cost or probably a drug supply problem in the public system
during the study period, which lowered affordability difﬁcult and
affected the treatment of these patients.20,21
Self-medicationwas identiﬁed in a few cases and involved over-
the-counter drugs. Responsible practice of self-medication should
be emphasized, both by the user and by the professional recom-
mending the medication.
Effectiveness-related drug-related problems
The high frequency of effectiveness-related problems (54.5%)
agrees with that reported by Baena et al2 (62.7%). Most of these
DRPs involved drugs of continuous use that require monitoring by
the healthcare team. In our system, continued and multiprofes-
sional care is not always provided due to deﬁciencies in the public
health service. Consequently, the patient may resort to seeking
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Table 3
Frequency of drug-related problems and possible causes related to their development.
Principle of pharmacotherapy Possible causes N◦ of cases (%) Frequency of DRP (%)
Indication Affordability 3 (2.4) 18 (14.6)
Non-adherence to treatment due to patient decision 6 (4.9)
Recently manifested problem 3 (2.4)
Pharmacological duplicity 2 (1.6)
Inadequate drug for disease 4 (3.2)
Effectiveness Addition of one more drug to mono-drug therapy necessary 8 (6.5) 67 (54.5)
Refractoriness 15 (12.2)
Bacterial resistance 5 (4.0)
Drug tolerance 1 (0.8)
Non-adherence reported by the patient (dose, time interval, chronopharmacology) 9 (7.3)
Drug-drug interaction 3 (2.4)
Inadequate dosage regimen 22 (17.9)
Dose at therapeutic range, but serum levels below the therapeutic range 2 (1.6)
Prescribed dose below the therapeutic window 2 (1.6)
Safety Adverse drug reaction 35 (28.5) 38 (30.9)
Sudden drug removal 1 (0.8)
Drug-drug interaction 1 (0.8)
Dose above the therapeutic window (toxic dose) 1 (0.8)
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RP: drug-related problems.
mergency care to solve any problems that appear during the
reatment.
Refractoriness to the treatment was considered as a possible
ause of unsuccessful chronic therapy in 15DRPs (12.2%). The other
ost common cause of effectiveness-related DRP was an inade-
uate dosage regimen (17.9%). This result may be related to the
requency of appointments with a physician, resulting in an inade-
uate dosage regimen due to the absence of follow-up. In patients
equiring the addition of more drugs to monotherapy, which usu-
lly occurs during the treatment of hypertension, closermonitoring
y health professionals could reduce these DRPs. These patients
ay not have had access to the required number of consultations
ithaphysician, ormaynothavekept scheduledconsultations, and
ould have maintained the same therapeutical scheme for longer
han recommended. Physicians see a large number of patients,
ampering assessment of signs and symptoms that optimize the
herapeutic plan. Furthermore, there is a lack of continuing educa-
ion programs for prescribers and other health professionals.
The possibility of non-adherence to treatment should not be
xcluded, as this is one of the factors most closely correlated to
neffectiveness.5 According to O’Connor,22 treatment failure is due
o medical inertia in about 75% of cases and to patients’ resistance
o adhering to the therapeutic plan in 25%. In our study, some of the
atients did not take the medication as recommended, suggesting
hat instruction on correct drug use requires more attention from
ealth professionals, as simple oral instruction is often insufﬁcient.
n some cases, patients forgot to take some drug dose(s). Factors
uch as thepatient’s age and thenumber of drugs prescribed should
lso be considered.
Ineffectiveness was attributed to bacterial resistance in ﬁve
RPs. Stricter monitoring by health professionals and more ade-
uate patient counseling could have prevented these patients from
eeding to seek ER care.
The remaining DRPs indicated prescription problems, such as
osages below the recommended level and lack of adequate assess-
ent of drug interactions, which could have been avoided.
Many of the patients (57.6%) came from the Hospital de Clíni-
as de Porto Alegre outpatient clinic and, due to the high frequency
f effectiveness-related DRPs, the use of the ER is probably inap-
ropriate, i.e., non-urgent cases or cases that could be managed in
he primary or secondary levels of care are treated by this service.
s other authors report, this result causes concern, as people that
se the ER inappropriately may be losing quality care. In addition,123 (100)
service to genuinely urgent patients is delayed, with overcrowd-
ing of the ER and other services that are normally used, such as
laboratories, radiology departments, etc.23,24
Safety-related problems
Thirty-ﬁve cases (97%) of safety-related DRP were suspected
of being ADR and, in one patient, two DRPs were suspected of
being ADR, totaling 36 suspected cases. According to Naranjo’s
algorithm,13 20 DRPs suspected of being ADR were classiﬁed as
probable and 16 as possible. No DRPs suspected of being ADR were
classiﬁed as deﬁnite or doubtful. Considering only the probable
suspected case, we found a 6% frequency of seeking ER care due
to ADRs, which is similar to the frequency range (1%-5%) reported
by other authors.25,26 The clinical manifestations observed ranged
from mild to severe.
Importantly, the ER medical team recorded the suspected ADRs
in only 30.5% of the cases. The pharmacovigilance system in Brazil
is relatively newandhence fewhealth professionals perceive drugs
as a potential cause of health problems.27 Additionally, there is a
lack of educationalmeasures to improve the safety of drug therapy,
which may be related to the high rate of ADRs.
Factors involved in drug-related problems
In 21 DRPs (17.1%), the patient was identiﬁed as the main
causative factor. The most common reasons were lack of adher-
ence to treatment due to neglect of one or more doses of medicines
for chronic use or the decision not to continue treatment and self-
medication.
The drug itself was linked to 36 DRPs (29.3%). Access to drug
information from the healthcare team could help to reduce pre-
dictable ADR. Thus, pharmacovigilance programs, structuring of
drug information centers and involvement of professionals special-
ized in drug use in the healthcare teams should be encouraged.
The remaining 66 DRPs (53.7%) can be attributed to the health
system itself or to healthcare professionals, speciﬁcally to the pre-
scriber, since in Brazil the participation of other professionals is still
low.We chose to group these cases into a single category. The study
design did not allowdata on previous visits to the ER to be collected
for amore detailed analysis. Inmany cases,medical inertiawas evi-
dent, but whether this was intrinsic or due to the organization of
the health system is unclear.
c Sanit. 2011;25(6):501–506 505
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What does the study add to the literature?
A high proportion of patients sought emergency service
due to drug related problems. Physician and health system
were probably responsible for 53.7% of the cases, while drug
and the patient were related to 29.3% and 17.0% of the prob-
lems observed, respectively. The health system organization
could contribute to reduce drug related problems by enabling
more frequent ambulatory visits with multidisciplinary team
cêutica. Brasília: Organizac¸ão Pan-Americana da Saúde; 2002.
13. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probabilityR.S. Andreazza et al. / Ga
rugs most commonly involved in drug-related problems
Chronic patients, who take drugs every day, are expected to
how a higher number of DRPs than patients who take drugs spo-
adically. The frequent association of drugs from these classes with
RPs has already been reported.28
Over-the-counter drugs should present no risk of use, but their
ossible use without proper instruction might have resulted in a
ealth problem that required the ER service. This possibility may
e related to the failure of the pharmacists to take responsibility
or rational self-medication in Brazil.
tudy limitations
One of the main limitations of this study is that it is based on
eported data, leading to considerable uncertainty on the possi-
le causes of the DRPs identiﬁed. This uncertainty was reduced by
ollecting information such as diagnosis and outcome of medical
xaminations from medical records.
Another issue is thatmultiple causes canbe involved inDRPsand
achof the factors listedas importantmaybeunderestimated, since
nly the most likely cause for each DRP was given. To estimate the
esponsibility of professionals, patients or the organization of the
ealth system and to evaluate the contribution of each factor to the
evelopment of a speciﬁc DRP, longitudinal studies are required,
s well as adjustments to the original questionnaire. Despite these
imitations, we believe that the data may be useful for designing
trategies to reduce the percentage of DRPs found.
onclusion
The data obtained in our study show that a high proportion
f patients sought ER care due to DRPs and that the risk of DRPs
ncreases with the number of drugs added to the therapy. These
esults reinforce the importance of considering drugs as a possible
ause of health problems and of the need to develop public policy
trategies to make the use of this resource more rational.
Since most patients had a low educational level, better counsel-
ng on disease(s), drug(s) and self-medication risks may positively
nﬂuence treatment adherence and safety. Our data suggest that
atients, especially chronic patients, are receiving insufﬁcient
ttention from health teams, possibly due to appointment over-
ooking and to a lack of training in the systematic evaluation of
harmacotherapy and counseling. The organization of the health
ystemcouldhelp to reduceDRPsbyenablingmore frequentoutpa-
ient clinic visits with a multidisciplinary team and implementing
pharmacotherapeutical monitoring system. Such measures may
ecrease demand for more complex care, such as that provided by
he ER service.
What is known about this topic?
Several studies have reported drug-induced health prob-
lems and report drug related problems as a frequent cause of
visits to emergency services and hospitalization. Data on this
topic are scarce in developing countries. The objective of this
study was to assess the frequency and types of drug related
problems inpatients seeking emergency care in a teachinghos-
pital in southern Brazil and to identify the possible causes and
drugs involved.and the implementation of a pharmacotherapeutic monitoring
method.
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